perphenazine (Trilafon)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradename: Trilafon.

Indications

Contraindications

Caution:

  • seizure disorder
  • safety in children < 12 years of age has not been established

pregnancy category = c

safety in lactation = ?

Dosage

Tabs: 2, 4, 8, 16 mg.

Liquid: 16 mg/5 mL.

Injection: 5 mg/mL (1 mL)

Pharmacokinetics

elimination via liver

elimination via kidney

Adverse effects

Drug interactions

Mechanism of action

high-potency antipsychotic agent

More general terms

Additional terms

Component of

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
  3. Jump up to: 3.0 3.1 Kaiser Permanente Northern California Regional Drug Formulary, 1998
  4. Jump up to: 4.0 4.1 4.2 Geriatric Review Syllabus, 8th edition (GRS8) Durso SC and Sullivan GN (eds) American Geriatrics Society, 2013

Database